What Is the ABOT ETF? Returns, Expense Ratio, Holdings, and Alternative ETFs at a Glance
The Abacus FCF Innovation Leaders ETF trades under the ticker ABOT and is an equity product that reflects both free cash flow profitability and R&D intensity. When reviewing its innovation-stock exposure, top holdings, quarterly distributions, and market outlook, investors should separate the strategy's defining features from its sources of volatility.
SubscribeWhat Is the Abacus FCF Innovation Leaders ETF?
The ABOT ETF tracks an index of innovation leaders among US companies, emphasizing free cash flow profitability and R&D intensity. Its core approach is passive, looking at a company's cash generation and its investment in innovation together.
It may suit long-term diversified investors who are interested in growth stocks and innovation themes but also want to apply a cash generation standard.
It is a passive (index-tracking) ETF managed by Abacus FCF Advisors.
How Does the Abacus FCF Innovation Leaders ETF Invest?
| Item | Details |
|---|---|
| Tracked index | FCF Innovation Leaders Index |
| Management style | Passive index tracking |
| Rebalancing frequency | Periodic adjustment |
| Distribution frequency | Quarterly distributions |
| Total expense ratio | 0.39% |
The fund screens US companies using free cash flow profitability and R&D intensity, then sets holding weights according to the index rules. Unlike an approach that picks stocks on growth expectations alone, its structure also looks at the sustainability of cash generation, and performance can differ depending on changes in the screening criteria and the market environment.
- Reflects both cash generation and R&D intensity
- Rules-based selection with a market-cap-weighted approach
Abacus FCF Innovation Leaders ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $4.6M, and the total expense ratio is 0.39% per year.
An ETF's trading volume and bid-ask spread can vary with market conditions, so it is worth checking your order method and actual trading conditions.
Abacus FCF Innovation Leaders ETF Performance and Trends
1-Year Price Performance
Dividend & Yield
52-Week Price RangeGiven a strategy that values both innovation investment and cash generation, return patterns can vary with growth-stock preferences, interest rate changes, and corporate earnings expectations. It is more appropriate to examine how the inclusion criteria work across market phases than to focus on short-term moves.
Fund flows can be affected by investor sentiment toward innovation stocks, market volatility, and the product's trading conditions. When buying or selling, check trading volume, the bid-ask spread, and changes in net assets together to gauge execution costs and liquidity risk.
Abacus FCF Innovation Leaders ETF Pros and Cons
A screening standard that looks at cash generation and innovation together is a strength, but the fund can be sensitive to the growth-stock environment and limited liquidity.
💪 Key Strengths
⚠️ Points to Watch
Abacus FCF Innovation Leaders ETF Alternative ETFs and Related Products
Among the ETFs in the comparison table, the FNDX ETF builds a US large-cap portfolio on fundamental criteria, while the PRF ETF applies similar criteria to a broad range of US stocks. The FNDA ETF focuses on small caps, so its company-size exposure may differ from that of the ABOT ETF. The JHMM ETF is a mid-cap product that uses multiple factors, and the QTUM ETF has more distinct exposure to the quantum technology theme. These products differ in investment scope and selection criteria, so investors should review costs, liquidity, and overlapping holdings together. The top holdings are NVDA, AAPL, AVGO, BMY, and QCOM.
Peer Comparison ETFs| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
 FNDX | Schwab Fundamental U.S. Large Company ETF | $32.71 | -0.6% | $28.6B | 0.25% | 1.44% | +23.3% |
 PRF | Invesco RAFI US 1000 ETF | $56.13 | -0.8% | $10.2B | 0.34% | 1.32% | +23.1% |
 FNDA | Schwab Fundamental U.S. Small Company ETF | $35.98 | -1.3% | $9.0B | 0.25% | 1.23% | +17.6% |
 RECS | Columbia Research Enhanced Core ETF | $44.93 | -1.5% | $6.2B | 0.15% | 0.72% | +10.0% |
 JHMM | John Hancock Multifactor Mid Cap ETF | $73.57 | -1.3% | $6.1B | 0.41% | 0.89% | +14.8% |
Top Holdings| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| NVDA | NVIDIA Corp | 0.11% | $204.64 | -4.2% | $4.93T | 25.9 | 0.38% |
| AAPL | Apple Inc | 0.10% | $344.63 | -1.2% | $5.03T | 39.5 | 0.32% |
| AVGO | Broadcom Inc | 0.08% | $326.08 | -5.5% | $1.56T | 41.6 | 0.8% |
| ABBV | Abbvie Inc | 0.03% | $294.89 | +1.4% | $521.1B | 83.4 | 2.32% |
| BMY | Bristol-Myers Squibb Co | 0.03% | $62.48 | +1.8% | $127.6B | 13.8 | 4.06% |
| QCOM | Qualcomm Inc | 0.03% | $164.79 | -11.1% | $176.0B | 19.1 | 2.2% |
| ABNB | Airbnb Inc | 0.03% | $164.39 | -1.2% | $98.4B | 37.4 | - |
Abacus FCF Innovation Leaders ETF Investor Checkpoints
Do not look only at the innovativeness of the holdings. Consider how the cash generation criteria actually change the portfolio's composition, along with trading conditions. Quarterly distributions are not a guarantee of an income level, so they should be interpreted in light of your long-term investment goals and risk tolerance.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| Management fee | Check ongoing costs and how they differ from similar products | Comparison needed |
| Trading conditions | Review trading volume and the bid-ask spread | Regular checks needed |
| Holding concentration | Check changes in the weights of innovation stocks and top holdings | Concentration review needed |
| Currency impact | Review the relationship between won-based returns and the dollar exchange rate | Currency exposure exists |
Share prices of innovative companies can be sensitive to changes in growth expectations, interest rates, and earnings outlooks. Investors should also consider that the index's screening rules may concentrate in particular industries or company traits, and that if the product's trading conditions worsen, trading costs and price dislocations could widen.
For those seeking a US equity ETF that reflects both cash generation and R&D activity, this fund can be a starting point for understanding the strategy. However, its screening method and holding characteristics differ from those of broad index products, so investors should judge it by comparing diversification effects, trading costs, and growth-stock risk together.
SubscribeDisclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of August 20, 2026.
Today's 5 AI picks, all free